Skip to main navigation
Skip to search
Skip to main content
The University of Brighton Home
Home
Profiles
Research units
Equipment
Projects
Research output
Activities
Student theses
Search by expertise, name or affiliation
Serine proteases in bone disease
Nadia Bouteldja, David J. Timson
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Serine proteases in bone disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Arthritis
33%
Arthropathy
33%
Bone Disease
100%
Bone Invasion
33%
Bone Tissue
66%
Cartilage
33%
Disease Process
33%
Effective Treatment
33%
Extracellular Matrix Protein 1 (ECM1)
33%
Growth Factor Binding
33%
Matrix Metalloproteases
33%
Metastatic Bone
33%
Molecular Disorder
33%
Multiple Pathways
33%
Overall Effect
33%
Pathological Process
33%
Physiological Processes
33%
Protease-activated Receptor 1 (PAR1)
33%
Proteolysis
33%
Serine Protease
100%
Serine Protease Inhibitor
33%
Signaling Molecules
33%
Strong Connections
33%
Systemic Effects
33%
Tissue Destruction
33%
Tissue Inflammation
33%
Transforming Growth Factor-β
33%
Medicine and Dentistry
Arthritis
33%
Arthropathy
33%
Bone Disease
100%
Bone Metastasis
33%
Bone Tissue
66%
Cancer Growth Factor
33%
Disease Process
33%
Molecular Disease
33%
Pathological Process
33%
Protein Degradation
33%
Proteinase Activated Receptor
33%
Scleroprotein
33%
Serine Proteinase
100%
Serine Proteinase Inhibitor
33%
Signaling Molecule
33%
Pharmacology, Toxicology and Pharmaceutical Science
Arthritis
33%
Arthropathy
33%
Bone Disease
100%
Bone Metastasis
33%
Cancer Growth Factor
33%
Diseases
33%
Inflammation
33%
Proteinase Activated Receptor
33%
Scleroprotein
33%
Serine Proteinase
100%
Serine Proteinase Inhibitor
33%
Biochemistry, Genetics and Molecular Biology
Agonist
33%
Cancer Growth Factor
33%
Enzyme
33%
Extracellular Matrix Proteins
33%
Molecular Disease
33%
Protease-Activated Receptor
33%
Proteolysis
33%
Scleroprotein
33%
Serine Protease
100%
Serine Protease Inhibitor
33%